Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02417038 · ClinicalTrials.gov registry record
Postoperative Respiratory Monitoring After Neuraxial Opioid Administration for Cesarean Delivery
A clinical trial of Respiratory Depression, sponsored by Stanford University.
- Completed
- Registry status
- 80
- Enrollment target
- 1
- Study location
NCT02417038: Completed study of Respiratory Depression, sponsored by Stanford University.
NCT02417038 is a study of Respiratory Depression that has completed, run by Stanford University. The registered enrollment target is 80 participants, above the 31-participant average among 4 other Respiratory Depression trials with a reported enrollment target (158% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02417038, a study of Respiratory Depression, has completed, sponsored by Stanford University.
- COMPLETED
- Registry status
- 80 participants
- Enrollment target
- 1
- Study location
Study Summary
Respiratory depression occurs in labor and delivery; noticeably when neuraxial opioids are given.Pathophysiological respiratory depression -failure to respond to hypercapnia or hypoxia - is challenging to measure clinically.American Society of Anesthesiologist guidelines recommend suitable respiratory monitoring for 24 hours post cesarean delivery (CD). Use of capnograph will enable us to assess breath-by-breathe respiration in a population receiving neuraxial opioids - potentially at risk for respiratory depression. Our aim is to assess our ability to capture maternal postpartum respiratory parameters in a cohort following opioid neuraxial administration for CD.
Primary Outcome
The Capnostream is a portable CO2 monitor with a pulse oximetry module to measure and record SpO2 and heart rate and provides waveform patterns for respratory rate and EtCO2 measurement.
Conditions Studied
Interventions
- DEVICE Capnostream
Study Locations (1)
California
- Lucile Packard Children's Hospital - Palo Alto
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 80 participants |
| Start Date | 2015-04 |
| Est. Completion | 2016-04-15 |
What the finished NCT02417038 record still lists
NCT02417038 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 80 participants, a relatively small participant target, above the 31-participant average among 4 other Respiratory Depression trials with a reported enrollment target (158% higher).
The record links to 1 condition, with Respiratory Depression appearing as the primary indexed condition, and to 1 intervention - of which Capnostream is the first listed.
NCT02417038 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT02417038 about?
NCT02417038 is a clinical study titled "Postoperative Respiratory Monitoring After Neuraxial Opioid Administration for Cesarean Delivery". Respiratory depression occurs in labor and delivery; noticeably when neuraxial opioids are given.Pathophysiological respiratory depression -failure to respond to hypercapnia or hypoxia - is challenging to measure clinically.American Society of Anesthesiologist guidelines recommend suitable respirato...
What is the current status of trial NCT02417038?
This trial is currently completed. The enrollment target is 80 participants. The study started on 2015-04. Estimated completion is 2016-04-15.
What conditions does trial NCT02417038 study?
This clinical trial studies the following conditions: Respiratory Depression.
What interventions are being tested in trial NCT02417038?
The interventions under investigation include: Capnostream (DEVICE).
Who is sponsoring clinical trial NCT02417038?
This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02417038 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Respiratory Depression
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
ENA-001 for Opioid Induced Respiratory Depression
ACTIVE NOT RECRUITING · Phase 1
-
The Effects of Ketamine on Respiratory Stimulation and Transpulmonary Pressures
COMPLETED · NA
-
Pupillary Unrest in Ambient Light, and Relationship to Opioid-Induced Respiratory Depression
COMPLETED · Phase 1
-
Effect of Opioids on Ventilation in Children With Obstructive Sleep Apnea
COMPLETED
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01243931 · 80 participants · NA
Optical Coherence Tomography Guided Transepithelial Phototherapeutic Keratectomy
- NCT01659203 · 80 participants · Phase 1
Proton or Photon RT for Retroperitoneal Sarcomas
- NCT01803451 · 80 participants · Early Phase 1
Glucagon-like Peptide 1, Glucose Metabolism and Gastric Bypass
- NCT01964859 · 80 participants · Phase 2
Feasibility Study for Fibroblast Autologous Skin Grafts
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia